Literature DB >> 8388382

Saccharomyces cerevisiae CDC25 (1028-1589) is a guanine nucleotide releasing factor for mammalian ras proteins and is oncogenic in NIH3T3 cells.

M C Chevallier-Multon1, F Schweighoffer, I Barlat, N Baudouy, I Fath, M Duchesne, B Tocqué.   

Abstract

The best characterized yeast guanine nucleotide releasing factor is CDC25, which acts on RAS and thereby stimulates cAMP production in Saccharomyces cerevisiae. In order to determine if CDC25 could be a specific GDP-GTP releasing factor for the mammalian proteins Ha-ras, Ki-ras, and N-ras, its functions were studied both in vitro and in NIH3T3 cells. The 561 amino acid composing the C-terminal domain of CDC25 (CDC25 C-domain) released guanine nucleotides (both GDP and GTP) from Ha-, Ki-, and N-ras but not from Rap1A, Rab5, and Rab11. CDC25 acted on oncogenically activated Ha-ras even if the last 23 amino acids (167-189) of the Ras proteins were not present. CDC25 transformed NIH3T3 cells; its transforming capacity was enhanced by overexpression of wild-type Ha-ras. CDC25 C-domain probably exerts its effects through the activation of cellular Ras proteins. These data suggest that the CDC25 C-domain can function as an upstream activator of Ras proteins in a heterologous system and therefore could be a useful tool to study the regulation of Ras activation by growth factor receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388382

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  CDC42 and FGD1 cause distinct signaling and transforming activities.

Authors:  I P Whitehead; K Abe; J L Gorski; C J Der
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

Review 2.  The Ras signal transduction pathway.

Authors:  R Khosravi-Far; C J Der
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

3.  Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity.

Authors:  L A Quilliam; S Y Huff; K M Rabun; W Wei; W Park; D Broek; C J Der
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

4.  A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors.

Authors:  J V Platko; D A Leonard; C N Adra; R J Shaw; R A Cerione; B Lim
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas.

Authors:  Maciej Tarnowski; Gabriela Schneider; Gabriele Amann; Geoffrey Clark; Peter Houghton; Frederic G Barr; Lukas Kenner; Mariusz Z Ratajczak; Magda Kucia
Journal:  Int J Oncol       Date:  2012-06-28       Impact factor: 5.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.